3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
23 23 0 0 0 0 0 0 0999 V2000
2.7383 1.8600 -0.1004 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5796 -2.2075 -0.5120 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.7150 0.9713 -0.0345 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8057 -0.6031 0.5315 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1385 -0.7794 0.0582 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9094 -0.1206 0.0203 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5055 -0.1948 0.0150 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2769 -0.8537 0.0549 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8668 1.2717 -0.0537 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5480 1.1975 -0.0591 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3618 1.9307 -0.0935 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7322 -0.9785 0.0517 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4222 -0.2182 0.0315 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4961 -1.2755 0.0900 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2258 -1.9381 0.1256 H 1 0 0 0 0 0 0 0 0 0 0 0
-1.7412 1.9066 -0.0838 H 1 0 0 0 0 0 0 0 0 0 0 0
0.3813 3.0159 -0.1514 H 1 0 0 0 0 0 0 0 0 0 0 0
-2.0860 -1.7945 0.1119 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.3816 -1.8712 1.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.4212 -1.9266 -0.7853 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.4820 -0.8025 0.0983 H 0 0 0 0 0 0 0 0 0 0 0 0
2.5683 2.8163 -0.1507 H 0 0 0 0 0 0 0 0 0 0 0 0
3.4103 -2.7285 -0.4824 H 0 0 0 0 0 0 0 0 0 0 0 0
1 10 1 0 0 0 0
1 22 1 0 0 0 0
2 12 1 0 0 0 0
2 23 1 0 0 0 0
3 13 2 0 0 0 0
4 12 2 0 0 0 0
5 6 1 0 0 0 0
5 13 1 0 0 0 0
5 18 1 0 0 0 0
6 8 2 0 0 0 0
6 9 1 0 0 0 0
7 8 1 0 0 0 0
7 10 2 0 0 0 0
7 12 1 0 0 0 0
8 15 1 0 0 0 0
9 11 2 0 0 0 0
9 16 1 0 0 0 0
10 11 1 0 0 0 0
11 17 1 0 0 0 0
13 14 1 0 0 0 0
14 19 1 0 0 0 0
14 20 1 0 0 0 0
14 21 1 0 0 0 0
M ISO 3 15 2 16 2 17 2
4. 国际命名与标识
4.1 IUPAC Name
3-acetamido-2,4,5-trideuterio-6-hydroxybenzoic acid
4.2 InChl
InChI=1S/C9H9NO4/c1-5(11)10-6-2-3-8(12)7(4-6)9(13)14/h2-4,12H,1H3,(H,10,11)(H,13,14)/i2D,3D,4D
4.3 InChlKey
GEFDRROBUCULOD-NRUYWUNFSA-N
4.4 Canonical SMILES
CC(=O)NC1=CC(=C(C=C1)O)C(=O)O
4.5 lsomeric SMILES
[2H]C1=C(C(=C(C(=C1NC(=O)C)[2H])C(=O)O)O)[2H]
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病